[AsCNP_P26] ポスター26
Schizophrenia 5

[AsCNP-P26-4] Deficiency of kynurenine 3-monooxygenase increases vulnerability to the PCP-induced behavioral abnormalities

^○Hisayoshi KUBOTA¹, Akihiro MOURI¹, Kazuo KUNISAWA¹, Moe NIIJIMA¹, Mami HIRAKAWA¹, Yuko MORI², Yasuko YAMAMOTO², Toshitaka NABESHIMA³, Kuniaki SAITO^{2, 3} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan., 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan.)